Expression of PU.1 and terminal differentiation of alveolar macrophages in newborn rats

Cell and Tissue Research

Volumn 329, Issue 1, 2007, Pages 71-79

  Iwabuchi, Haruko ^a   Kawasaki, Takashi ^a   Yamamoto, Takashi ^a   Uchiyama, Makoto ^a   Nakata, Koh ^b   Naito, Makoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Alveolar macrophage; GM CSF; PU.1; Rat (Wistar, newborn); Surfactant

Indexed keywords

ACID PHOSPHATASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MANNOSE RECEPTOR; PHOSPHATASE; SCAVENGER RECEPTOR; SURFACTANT; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LYSOSOME; MICROVILLUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STRUCTURE ANALYSIS; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, ALVEOLAR; MICROVILLI; PROTO-ONCOGENE PROTEINS; PULMONARY SURFACTANTS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; TIME FACTORS; TRANS-ACTIVATORS;

RATTUS;

EID: 34247648052     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0405-7     Document Type: Article

References (41)

1. Bellanti JA, Nerurkar LS, Zeligs BJ (1979) Host defenses in the fetus and neonate: studies of the alveolar macrophage during maturation. Pediatrics 64:726-739
2. Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MS, Thomassen MJ (2003) PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 285:L1132-L1136
3. Bry K, Hallman M, Teramo K, Waffarn F, Lappalainen U (1997) Granulocyte-macrophage colony-stimulating factor in amniotic fluid and in airway specimens of newborn infants. Pediatr Res 41:105-109
4. Burgess AW, Metcalf D (1980) The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56:947-958
5. Burgess AW, Kamakaris J, Metcalf D (1977) Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 252:1998-2003
6. Chen H, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang DE, Tenen DG (1995) Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918-2928
7. Churchill L, Friedman B, Schleimer RP, Proud D (1992) Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 75:189-195
8. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, Kay AB (1992) Expression and generation of interleukin-8, IL-6 and granulocyte- macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1β and tumor necrosis factor-α. Immunology 77:330-337
9. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713-716
10. Fraser J, Walls M, McGuire W (2006) Respiratory complications of preterm birth. BMJ 329:962-965
11. Gasson JC (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131-1145
12. Golde DW, Territo M, Finley TN, Cline MJ (1976) Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 85:304-309
13. Hansen T, Corbet A (1998) Lung development and function In: Taeusch WH, Ballard RA (eds) Avery's disease of the newborn, 7th edn. Saunders, Philadelphia, pp 541-551
14. Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA (1996) Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest 97:649-655
15. Huffman Reed JA, Rice WR, Zsengeller ZK, Wert SE, Dranoff G, Whitsett JA (1997) GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol Lung Cell Mol Physiol 273:L715-L725
16. Jacobs H, Jobe A, Ikegami M, Jones S (1982) Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits. J Biol Chem 257:1805-1810
17. Jobe AH, Ikegami M (1993) Surfactant metabolism. Clin Perinatol 20:683-696
18. Jobe A, Ikegami M, Jacobs H (1981) Changes in the amount of lung and airway phosphatidylcholine in 0.5-12.5-day-old rabbits. Biochimi Biophys Acta 664:182-187
19. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, Nakata K (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190:875-880
20. Kurland G, Cheung AT, Miller ME, Ayin SA, Cho MM, Ford EW (1988) The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys. Pediatr Res 23:293-297
21. Lee PT, Holt PG, McWilliam AS (2001a) Ontogeny of rat pulmonary alveolar macrophage function: evidence for a selective deficiency in IL-10 and nitric oxide production by newborn alveolar macrophages. Cytokine 15:53-57
22. Lee PT, Holt PG, McWilliam AS (2001b) Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator. Eur J Immunol 31:2347-2356
23. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15:5647-5658
24. Nakata K, Akagawa KS, Fukayama M, Hayashi Y, Kadokura M, Tokunaga T (1991) Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J Immunol 147:1266-1272
25. Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D,McNeil T, Azuma S, Yoshida S, Toyoda Y, Arai K, Miyajima A, Murray R (1995) Mice deficient for the IL-3/GM-CSF/IL-5β receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal. Immunity 2:211-222
26. Ohashi T, Pinkerton K, Ikegami M, Jobe AH (1994) Changes in alveolar surface area, surfactant protein A, and saturated phosphatidylcholine with postnatal rat lung growth. Pediatr Res 35:685-689
27. Papoff P, Christensen RD, Calhoun DA, Juul SE (2001) Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome. Biol Neonate 80:133-141
28. Presneill JJ, Nakata K, Inoue Y, Seymour JF (2004) Pulmonary alveolar proteinosis. Clin Chest Med 25:593-613
29. Randell SH, Silbajoris R, Young SL (1991) Ontogeny of rat lung type II cells correlated with surfactant lipid and surfactant apoprotein expression. Am J Physiol Cell Mol Physiol 260:L562-L570
30. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol 276:L556-L563
31. Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA, Begley CG (1995) Hematopoietic and lung abnormalities in mice with a null mutation of the common ? subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 92:9565-9569
32. Rodriguez RJ (2003) Management of respiratory distress syndrome: an update. Respir Care 48:279-286
33. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15:557-567
34. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JAM, Maher DW, Cebon J, Sinickas V, Dunn AR (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592-5596
35. Suresh GK, Soll RF (2005) Overview of surfactant replacement trials. J Perinatol 25:S40-S44
36. Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, Nakata K (1999) Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macropharge colony stimulating factor. FEBS Lett 442:246-250
37. Trapnell BC, Whitsett JA (2002) GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775-802
38. Trapnell BC, Whitsett JA, Nakata K (2003) Pulmonary alveolar proteinosis. N Engl J Med 349:2527-2539
39. Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsushita I, Seymour JF, Oh-eda M, Ishige I, Eishi Y, Kitamura T, Yamada Y, Hanaoka K, Keicho N (2004) High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 103:1089-1098
40. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG (1994) Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci USA 91:7932-7936
41. Worgall S, Singh R, Leopold PL, Kaner RJ, Hackett NR, Topf N, Moore MAS, Crystal RG(1999) Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA. Blood 93:655-666